Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Astria Therapeutics, Inc. (ATXS) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/10/2023 SC 13G FMR LLC reports a 12.8% stake in ASTRIA THERAPEUTICS INC
12/22/2022 SC 13G Deep Track Capital, LP reports a 7.3% stake in Astria Therapeutics, Inc.
12/21/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/08/2022 SC 13G Vivo Opportunity, LLC reports a 7.1% stake in Astria Therapeutics, Inc.
09/02/2022 SC 13G Cormorant Asset Management, LP reports a 5.4% stake in Astria Therapeutics, Inc.
06/17/2021 SC 13G Fairmount Funds Management LLC reports a 5.3% stake in Catabasis Pharmaceuticals, Inc.
06/15/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/02/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/19/2019 SC 13G ARMISTICE CAPITAL, LLC reports a 5% stake in Catabasis Pharmaceuticals, Inc.
07/10/2018 SC 13G FEDERATED INVESTORS INC reports a 14.7% stake in CATABASIS PHARMACEUTICALS, INC.
07/02/2018 SC 13G ARMISTICE CAPITAL, LLC reports a 5% stake in Catabasis Pharmaceuticals, Inc.
06/28/2018 SC 13G Stonepine Capital Management, LLC reports a 6.5% stake in Catabasis Pharmaceuticals, Inc.
06/25/2018 SC 13G Empery Asset Management, LP reports a 7% stake in Catabasis Pharmaceuticals, Inc.
02/23/2018 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/16/2016 SC 13G ADVANCED TECHNOLOGY VENTURES VII LP reports a 7.4% stake in Catabasis Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy